Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651 1682
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17916528 | SHEWANELLA ATLANTICA-DERIVED PROTEIN-EXPRESSING MICROORGANISM AND L-AMINO ACID PRODUCTION METHOD USING SAME | Non-Final OA | CJ CheilJedang Corporation |
| 18561123 | METHODS OF PRODUCTING HMO BLEND PROFILES WITH LNFP-1 AND 2'-FL AS THE PREDOMINANT COMPOUNDS | Non-Final OA | DSM IP Assets B.V. |
| 18026678 | METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS | Final Rejection | AMGEN INC. |
| 18252865 | ENGINEERED CHIMERIC ANTIMICROBIAL AGENTS AGAINST GRAM-POSITIVE BACTERIA | Final Rejection | Massachusetts Institute of Technology |
| 18250913 | APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT | Final Rejection | NATIONAL CANCER CENTER |
| 18022004 | MODIFIED SERINE PROTEASE PROPROTEINS | Final Rejection | The University of Chicago |
| 18558026 | CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE | Non-Final OA | EMORY UNIVERSITY |
| 18400179 | GENETICALLY MODIFIED MICROORGANISM, PREPARATION METHOD THEREOF, AND METHOD OF PRODUCING TARGET CHEMICAL | Non-Final OA | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE |
| 18021847 | COMBINATION THERAPY COMPRISING HER-2-DC1 VACCINE, A PROBIOTIC, AND SEMAPHORIN | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 17778488 | METHODS OF FERMENTATION OF RECOMBINANT BACILLUS SPORES | Non-Final OA | Bayer CropScience LLC |
| 18275331 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES | Non-Final OA | UNIVERSITÉ DE MONTPELLIER |
| 18699491 | MICROORGANISM HAVING ABILITY TO PRODUCE N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE AND METHOD FOR PRODUCING N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE USING SAID MICROORGANISM | Non-Final OA | KYOWA HAKKO BIO CO., LTD. |
| 18697727 | NOVEL PROBIOTICS AND USE THEREOF | Non-Final OA | NVP HEALTHCARE CO., LTD. |
| 17782279 | ENZYME COMPOSITIONS AND USES THEREOF | Non-Final OA | Novozymes A/S |
| 17756096 | INTENSIFIED VIRUS FILTRATION USING DIAFILTRATION BUFFER | Final Rejection | EMD Millipore Corporation |
| 18291310 | NUCLEOTIDE PROBIOTIC CAPSULE FOR DELAYING AGING | Non-Final OA | Yusong CHEN |
| 18033492 | ENHANCED HYT-INDUCED PROTEIN DEGRADATION USING LIPID NANOPARTICLE DELIVERY | Final Rejection | Trustees of Tufts College |
| 18575412 | Compositions For and Methods of Promoting Respiratory Health | Non-Final OA | Ann & Robert H. Lurie Children's Hospital of Chicago |
| 18285548 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Non-Final OA | Vedanta Biosciences, Inc. |
| 18283313 | Perioperative Innate Immune Priming in Cancer Therapy | Non-Final OA | Qu Biologics Inc. |
| 18037632 | POLYPEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS | Non-Final OA | CC BIOTECH LTD. |
| 18135668 | COMPOSITIONS AND METHODS FOR PRODUCING BICARBONATE AND MINERALS | Non-Final OA | ANDES AG, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy